Publication | Closed Access

Substituted 3-((Z)-2-(4-nitrophenyl)-2-(1H-tetrazol-5-yl) vinyl)-4H-chromen-4-ones as novel anti-MRSA agents: Synthesis, SAR, and in-vitro assessment

Medicinal ChemistryNatural SciencesNovel Anti-mrsa AgentsMedicineIn-vitro AssessmentAntimicrobial CompoundChemistryPharmacologyPharmaceutical ChemistrySynthetic ChemistryDrug Discovery